Skip to main content
HHMI BioInteractive
  • Español
  • Site Search
  • Log In/Create Account
  • BioInteractive Resources
  • Planning Tools
  • Professional Development
  • About Us

You are here

  1. Science News
Short Article

Health program offers free HIV prevention drug to uninsured

By: Lauran Neergaard
12.03.19
Source
Associated Press
Topics
Microbiology
Saved By
1 Users
Share This
A man in suit.
In this July 16, 2019, file photo, Health and Human Services Secretary Alex Azar pauses while speaking during a Cabinet meeting at the White House, in Washington. The government opened a new program Tuesday to provide an HIV prevention drug for free to people who need the protection but have no insurance to pay for it. (AP Photo/Alex Brandon, File)

The government launched a new program on Tuesday to provide an HIV prevention drug for free to people who need the protection but have no insurance to pay for it.

Taking certain anti-HIV drugs every day dramatically reduces the chances that someone who is still healthy becomes infected through sex or injection drug use. But only about 18% of the 1.2 million Americans who might benefit got a prescription last year, Health and Human Services Secretary Alex Azar said. And for those without insurance, the drugs can cost up to $2,000 a month.

Expanding access to what’s called PrEP — for pre-exposure prophylaxis — is one key to the Trump administration’s ambitious goal of ending the nation’s HIV epidemic by 2030.

“We have the tools to stop the spread of HIV in its tracks. It’s about execution,” Azar told The Associated Press.

The HHS program is for the uninsured to seek free PrEP doses. Drugmaker Gilead Sciences Inc. has agreed to donate enough of its HIV prevention medicines for up to 200,000 people a year over 10 years.

To qualify, people must have a valid prescription and a negative HIV test and must lack prescription drug coverage. They can apply through a new website, GetYourPrEP.com. Once approved, they’ll be provided a card with a number necessary for their pharmacy to fill the prescription at no cost, officials said.

The uninsured aren’t the only the concern. Even though most insurers cover PrEP, co-pays still can be obstacles, especially for people with high-deductible plans.

Gilead, based in Foster City, California, sells the only two brands of PrEP, Truvada and Descovy, approved in the U.S. A cheaper generic version of Truvada is expected next fall.

Getting doctors to ask their patients about HIV risk factors and educating the public about PrEP also are hurdles. PrEP use has increased since 2016, when just 9% of those qualified got a prescription for HIV prevention, said Dr. Jonathan Mermin, of the Centers for Disease Control and Prevention.

The increase is a good sign, but “progress is not fast enough,” Mermin said.

There are about 38,000 new HIV infections in the U.S. each year. President Donald Trump’s administration aims to reduce those by 75% in five years and by 90% in 10 years.

Azar said the Gilead donation, first announced in May, wasn’t affected by a patent-infringement lawsuit HHS recently filed against the company, arguing taxpayer-funded research helped lead to the recognition that certain drugs initially used to treat HIV also could prevent it.

Posting of this article is courtesy of the Associated Press (AP). The article originally appeared as part of the AP’s Health & Science reporting, which is supported by the HHMI Department of Science Education.

View Original Article

Use This With

Video Resource
HIV Life Cycle
Activity Resource
Viral DNA Integration
Video Resource
Treating HIV Infection with a Reverse Transcriptase Inhibitor

Related Science News

Science News
Tracking microbes people carry may predict future health

We share our bodies with trillions of microbes that are critical to staying healthy, but now scientists are getting a much-needed close look at how those bugs can get out of whack and spur disease.

Microbiology
Science News
Dikembe Mutombo records Ebola messages for US officials

Unable to send disease fighters to help battle one of the deadliest Ebola outbreaks in history, U.S. health officials are turning to basketball hall of famer Dikembe Mutombo for help.

Microbiology
Science News
Vaccine panel gives nod to HPV shots for men up to age 26

A vaccine against cervical and other cancers should be recommended for both men and women up to age 26, a U.S. government advisory panel decided Wednesday.

Microbiology
HHMI BioInteractive
  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • Newsletter Signup
  • HHMI.org
  • Terms of Use
  • Privacy Policy
  • Accessibility